Clinical Trial Update: Individualized, Target-Driven Treatment Of Children With Idiopathic Short Stature [Phase 3]

View source ↗

Summary

Pfizer-sponsored Phase 3 clinical trial evaluating an individualized, target-driven treatment approach in children with idiopathic short stature has completed a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Short Stature

Snippet

Sponsor: Pfizer | Conditions: Idiopathic Short Stature | Phase 3 | Status: COMPLETED | Results posted: 2013-11-13